- Home
- AUTL vs OLP Comparison
AUTL vs OLP Comparison
Compare AUTL & OLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUTL | OLP |
|---|---|---|
| Founded | 2014 | 1982 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.2M | 550.9M |
| IPO Year | 2025 | 1995 |
Fundamental Metrics
Financial Performance| Metric | AUTL | OLP |
|---|---|---|
| Price | $1.90 | $23.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $8.50 | ★ $26.75 |
| AVG Volume (30 Days) | ★ 2.3M | 53.7K |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 7.88% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.00 |
| Revenue | $10,120,000.00 | ★ $82,740,000.00 |
| Revenue This Year | $80.32 | $11.98 |
| Revenue Next Year | $53.96 | $3.71 |
| P/E Ratio | ★ N/A | $23.49 |
| Revenue Growth | ★ 496.00 | 1.02 |
| 52 Week Low | $1.18 | $19.62 |
| 52 Week High | $2.58 | $25.88 |
Technical Indicators
Market Signals| Indicator | AUTL | OLP |
|---|---|---|
| Relative Strength Index (RSI) | 41.17 | 33.63 |
| Support Level | $1.37 | $22.36 |
| Resistance Level | $2.07 | $23.63 |
| Average True Range (ATR) | 0.10 | 0.41 |
| MACD | -0.07 | -0.08 |
| Stochastic Oscillator | 1.79 | 6.75 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
About OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred and two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.